Stage II embryonal predominant NSGCT: Minimizing treatment burden.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Oncology
Published
2025-02-10
DOI
https://doi.org/10.1200/jco.2025.43.5_suppl.634
Primary Topic
Prenatal Screening and Diagnostics
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Stage II embryonal predominant NSGCT: Minimizing treatment burden.

Jiping Zeng, Timothy A. Masterson, Clint Cary, Parth Thakker et al.
Journal of Clinical Oncology
Prenatal Screening and Diagnostics
article

Stage II embryonal predominant NSGCT: Minimizing treatment burden.

Jiping Zeng, Timothy A. Masterson, Clint Cary, Parth Thakker, Jennifer King, Lawrence H. Einhorn, Nabil Adra, Tareq Salous
article en

Abstract

No abstract available for this paper.
Journal of Clinical OncologyVol. 43(5_suppl)
Indiana University Health (US), Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indiana University School of Medicine, Indiana University – Purdue University Indianapolis (US)
Good health and well-being
Openalex Percentile: Top 96%
Prenatal Screening and Diagnostics
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Stage II embryonal predominant NSGCT: Minimizing treatment burden. — Jiping Zeng, Timothy A. Masterson, et al. · Journal of Clinical Oncology (2025) | TGRS Research Map | TGRS